Skip to Content

Publications Search - Abstract View

Title: Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Authors: Meyer KB,  O'Reilly M,  Michailidou K,  Carlebur S,  Edwards SL,  French JD,  Prathalingham R,  Dennis J,  Bolla MK,  Wang Q,  de Santiago I,  Hopper JL,  Tsimiklis H,  Apicella C,  Southey MC,  Schmidt MK,  Broeks A,  Van 't Veer LJ,  Hogervorst FB,  Muir K,  Lophatananon A,  Stewart-Brown S,  Siriwanarangsan P,  Fasching PA,  Lux MP,  Ekici AB,  Beckmann MW,  Peto J,  Dos Santos Silva I,  Fletcher O,  Johnson N,  Sawyer EJ,  Tomlinson I,  Kerin MJ,  Miller N,  Marme F,  Schneeweiss A,  Sohn C,  Burwinkel B,  Guénel P,  Truong T,  Laurent-Puig P,  Menegaux F,  Bojesen SE,  Nordestgaard BG,  Nielsen SF,  Flyger H,  Milne RL,  Zamora MP,  Arias JI,  Benitez J,  Neuhausen S,  Anton-Culver H,  Ziogas A,  Dur CC,  Brenner H,  Müller H,  Arndt V,  Stegmaier C,  Meindl A,  Schmutzler RK,  Engel C,  Ditsch N,  Brauch H,  Brüning T,  Ko YD,  GENICA Network,  Nevanlinna H,  Muranen TA,  Aittomäki K,  Blomqvist C,  Matsuo K,  Ito H,  Iwata H,  Yatabe Y,  Dörk T,  Helbig S,  Bogdanova NV,  Lindblom A,  Margolin S,  Mannermaa A,  Kataja V,  Kosma VM,  Hartikainen JM,  Chenevix-Trench G,  kConFab Investigators,  Australian Ovarian Cancer Study Group,  Wu AH,  Tseng CC,  Van Den Berg D,  Stram DO,  Lambrechts D,  Thienpont B,  Christiaens MR,  Smeets A,  Chang-Claude J,  Rudolph A,  Seibold P,  Flesch-Janys D,  Radice P,  Peterlongo P,  Bonanni B,  Bernard L,  Couch FJ,  Olson JE,  Wang X,  Purrington K,  Giles GG,  Severi G,  Baglietto L,  McLean C,  Haiman CA,  Henderson BE,  Schumacher F,  Le Marchand L,  Simard J,  Goldberg MS,  Labrèche F,  Dumont M,  Teo SH,  Yip CH,  Phuah SY,  Kristensen V,  Grenaker Alnæs G,  Børresen-Dale AL,  Zheng W,  Deming-Halverson S,  Shrubsole M,  Long J,  Winqvist R,  Pylkäs K,  Jukkola-Vuorinen A,  Kauppila S,  Andrulis IL,  Knight JA,  Glendon G,  Tchatchou S,  Devilee P,  Tollenaar RA,  Seynaeve CM,  García-Closas M,  Figueroa J,  Chanock SJ,  Lissowska J,  Czene K,  Darabi H,  Eriksson K,  Hooning MJ,  Martens JW,  van den Ouweland AM,  van Deurzen CH,  Hall P,  Li J,  Liu J,  Humphreys K,  Shu XO,  Lu W,  Gao YT,  Cai H,  Cox A,  Reed MW,  Blot W,  Signorello LB,  Cai Q,  Pharoah PD,  Ghoussaini M,  Harrington P,  Tyrer J,  Kang D,  Choi JY,  Park SK,  Noh DY,  Hartman M,  Hui M,  Lim WY,  Buhari SA,  Hamann U,  Försti A,  Rüdiger T,  Ulmer HU,  Jakubowska A,  Lubinski J,  Jaworska K,  Durda K,  Sangrajrang S,  Gaborieau V,  Brennan P,  McKay J,  Vachon C,  Slager S,  Fostira F,  Pilarski R,  Shen CY,  Hsiung CN,  Wu PE,  Hou MF,  Swerdlow A,  Ashworth A,  Orr N,  Schoemaker MJ,  Ponder BA,  Dunning AM,  Easton DF
Journal: Am J Hum Genet
Date: 2013 Dec 5
Branches: BB, HREB, LTG, OD, OEEB
PubMed ID: 24290378
PMC ID: PMC3852923
Abstract: The 10q26 locus in the second intron of FGFR2 is the locus most strongly associated with estrogen-receptor-positive breast cancer in genome-wide association studies. We conducted fine-scale mapping in case-control studies genotyped with a custom chip (iCOGS), comprising 41 studies (n = 89,050) of European ancestry, 9 Asian ancestry studies (n = 13,983), and 2 African ancestry studies (n = 2,028) from the Breast Cancer Association Consortium. We identified three statistically independent risk signals within the locus. Within risk signals 1 and 3, genetic analysis identified five and two variants, respectively, highly correlated with the most strongly associated SNPs. By using a combination of genetic fine mapping, data on DNase hypersensitivity, and electrophoretic mobility shift assays to study protein-DNA binding, we identified rs35054928, rs2981578, and rs45631563 as putative functional SNPs. Chromatin immunoprecipitation showed that FOXA1 preferentially bound to the risk-associated allele (C) of rs2981578 and was able to recruit ERα to this site in an allele-specific manner, whereas E2F1 preferentially bound the risk variant of rs35054928. The risk alleles were preferentially found in open chromatin and bound by Ser5 phosphorylated RNA polymerase II, suggesting that the risk alleles are associated with changes in transcription. Chromatin conformation capture demonstrated that the risk region was able to interact with the promoter of FGFR2, the likely target gene of this risk region. A role for FOXA1 in mediating breast cancer susceptibility at this locus is consistent with the finding that the FGFR2 risk locus primarily predisposes to estrogen-receptor-positive disease.